


Achieving 'normalization' in hemophilia care, while improving patient outcomes, introduces substantial financial burdens on healthcare systems. Payers must grapple with the high costs of novel therapies and ensure equitable access.

The presence of nucleated red blood cells (NRBCs) on a peripheral blood smear in the setting of macrocytic anemia warrants prompt investigation. This finding, while rare, demands a systematic approach to differentiate between vitamin B12 deficiency, severe ...

The presence of early erythroblasts on peripheral blood film in severe vitamin B12 deficiency may indicate a more profound disruption of bone marrow function than previously appreciated. Clinicians should consider aggressive intervention and vigilant monito...

For young adults with hemophilia , the concept of 'normalization' in treatment can significantly impact their ability to pursue demanding careers and lifestyles. A case study highlights the importance of aligning treatment goals with individual patient aspi...

The concept of 'normalization' in hemophilia care shifts the focus from merely preventing bleeds to enabling patients to live full, unrestricted lives. Clinicians need to proactively address lifestyle goals, activity levels, and psychosocial well-being in a...

Immune thrombocytopenia is associated with bleeding and infection risk, yet long-term mortality patterns remain heterogeneous. A 24-year U.S. analysis mapped trends and disparities by age, sex, race and comorbidity, highlighting higher-risk subgroups. Findi...

In immune thrombocytopenia , U.S. mortality patterns were quantified using age-adjusted rates and subgroup analyses across 24 years. The analysis evaluated temporal trends, sex and race strata, and coding-based case definitions. Findings indicate heterogene...

Immune thrombocytopenia mortality patterns over 24 years show persistent disparities by demographic and contextual factors, underscoring uneven outcomes despite therapeutic advances. An analysis of national data identified directional gaps that likely refle...

Immune thrombocytopenia was evaluated for US ITP-related mortality over 24 years, mapping temporal patterns and sociodemographic disparities. Signals suggest differential burdens by age, sex, race-ethnicity, and care context , with implications for bleeding...

In immune thrombocytopenia, a 24-year U.S. analysis characterizes mortality patterns and disparities across age, sex, and race, contextualized against evolving therapies and supportive care. The work highlights persistent risk heterogeneity and signals gaps...